Back to Search
DIANA HUNTSMAN, PHARMD, CDCES
PHARMD, CDCES
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1588079172Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
68068(CA)
Research & Publications (20)
Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
PMID 11419427·N Engl J Med·2001
5-case
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
PMID 19636701·Breast Cancer Res Treat·2010
8-other
Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
PMID 19408054·Ann Surg Oncol·2009
8-other
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.
PMID 19136932·Mod Pathol·2009
8-other
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.
PMID 19366795·Cancer Res·2009
8-other
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
PMID 18830127·Am J Surg Pathol·2009
4-observational
The fallopian tube: primary site of most pelvic high-grade serous carcinomas.
PMID 19258943·Int J Gynecol Cancer·2009
6-review
Germline CDH1 deletions in hereditary diffuse gastric cancer families.
PMID 19168852·Hum Mol Genet·2009
8-other
Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
PMID 19269290·Gastroenterology·2009
4-observational
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss.
PMID 19060844·Mod Pathol·2009
8-other
Multiple granular cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11.
PMID 19054014·Clin Genet·2009
5-case
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.
PMID 19476653·BMC Cancer·2009
8-other
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancer.
PMID 18834223·Arch Pathol Lab Med·2008
4-observational
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
PMID 19053170·PLoS Med·2008
8-other
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
PMID 19001334·J Clin Oncol·2008
8-other
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
PMID 18925950·Breast Cancer Res·2008
4-observational
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.
PMID 19383354·Mol Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 26001 REDLANDS BLVD
REDLANDS, CA 92373 - Phone
- (909) 825-7084
Quick Facts
- NPI
- 1588079172
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile